miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
Open Access
- 16 July 2015
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 6 (7) , e1823
Abstract
The ErbB tyrosine kinase receptor family has been shown to have an important role in tumorigenesis, and the expression of its receptor members is frequently deregulated in many types of solid tumors. Various drugs targeting these receptors have been approved for cancer treatment. Particularly, in breast cancer, anti-Her2/EGFR molecules represent the standard therapy for Her2-positive malignancies. However, in a number of cases, the tumor relapses or progresses thus suggesting that not all cancer cells have been targeted. One possibility is that a subset of cells capable of regenerating the tumor, such as cancer stem cells (CSCs), may not respond to these therapeutic agents. Accumulating evidences indicate that miR-205-5p is significantly downregulated in breast tumors compared with normal breast tissue and acts as a tumor suppressor directly targeting oncogenes such as Zeb1 and ErbB3. In this study, we report that miR-205-5p is highly expressed in BCSCs and represses directly ERBB2 and indirectly EGFR leading to resistance to targeted therapy. Furthermore, we show that miR-205-5p directly regulates the expression of p63 which is in turn involved in the EGFR expression suggesting a miR-205/p63/EGFR regulation.Keywords
This publication has 41 references indexed in Scilit:
- MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathwayNature Cell Biology, 2013
- miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer CellsPLOS ONE, 2012
- p63/p73 in the control of cell cycle and cell deathExperimental Cell Research, 2012
- Role of microRNAs in the Regulation of Breast Cancer Stem CellsJournal of Mammary Gland Biology and Neoplasia, 2012
- Resistance to HER2-directed antibodies and tyrosine kinase inhibitorsCancer Biology & Therapy, 2011
- MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cellsJournal of Translational Medicine, 2011
- miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase CεCancer Research, 2009
- miR-203 represses ‘stemness’ by repressing ΔNp63Cell Death & Differentiation, 2008
- MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer ManagementClinical Cancer Research, 2008
- Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast CancerCancer Research, 2007